Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,751 results for "Product Liability Law & Strategy"...

Government Overpayment
It is not fraud when the government mistakenly overpays businesses who participate in government programs or otherwise receive federal funds. But a false statement made to retain an overpayment is a "reverse false claim" in violation of the False Claims Act (FCA).
Drug & Device News
A roundup of recent developments.
NJ Supreme Court Extends Long-Arm Jurisdiction to Foreign Manufacturers
On Feb. 2 of this year, the Supreme Court of New Jersey held that a foreign manufacturer of an industrial recycling machine is subject to New Jersey's long-arm jurisdiction under the stream-of-commerce theory. This has broad implications.
Third Circuit Rejects Defective Sperm As Basis for Product Liability Suit
On April 1, the Third Circuit upheld a June 2009 decision by U.S. District Judge Thomas N. O'Neill Jr. that rejected claims by a mother and her daughter who suffers from Fragile X syndrome, a mutation known to cause a group of serious maladies.
Practice Tip: Admissibility of Expert Opinions
The purpose of this article is to provide an update of the themes and factors that were important to courts in 2009 in reaching their decisions on the admissibility of expert witness opinions.
When Is an Expert Not an Expert?
The defense of a pharmaceutical or medical device product liability case often turns on the testimony of the core treating physicians. As defense counsel, we often are left holding our breath waiting to see how the physicians testify at their depositions or at trial. So do the plaintiffs.
Physician and Pharmaceutical Industry Relationships
According to a national survey of doctors published in <i>The New England Journal of Medicine</i>, 94% of physicians have "a relationship" with the pharmaceutical, medical device or related industries. A research firm recently estimated that drug companies spend over $20 billion annually marketing directly to physicians. With statistics like these, it is not surprising that the public is becoming concerned that these ties may influence how medications are developed, marketed and prescribed.
What Works and What Doesn't in Legal Advertising
In advertising, it's amazing what works and what doesn't work. It isn't always what you think it is.
Antitrust Issues in IP Settlements
This article discusses some common IP settlement terms that may give rise to antitrust liability.
Ten Issues to Consider in Launching a Social Media Presence
Intellectual property and advertising issues have emerged in the forefront of social media law. This article provides a brief look at 10 of these issues.

MOST POPULAR STORIES